Squarepoint’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Sell |
329,392
-113,401
| -26% | -$1.96M | 0.01% | 742 |
|
|
2025
Q1 | $9.68M | Buy |
442,793
+275,831
| +165% | +$6.03M | 0.01% | 564 |
|
|
2024
Q4 | $5.33M | Buy |
166,962
+76,621
| +85% | +$2.44M | 0.01% | 743 |
|
|
2024
Q3 | $2.61M | Buy |
90,341
+29,083
| +47% | +$839K | ﹤0.01% | 1022 |
|
|
2024
Q2 | $2.35M | Buy |
+61,258
| New | +$2.35M | ﹤0.01% | 1001 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2411 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2486 |
|
|
2022
Q4 | – | Sell |
-101,085
| Closed | -$6.9M | – | 2242 |
|
|
2022
Q3 | $6.9M | Buy |
101,085
+50,705
| +101% | +$3.46M | 0.03% | 367 |
|
|
2022
Q2 | $2.28M | Buy |
50,380
+31,082
| +161% | +$1.41M | 0.01% | 703 |
|
|
2022
Q1 | $981K | Buy |
+19,298
| New | +$981K | ﹤0.01% | 1148 |
|
|
2021
Q3 | – | Sell |
-5,344
| Closed | -$338K | – | 2211 |
|
|
2021
Q2 | $338K | Buy |
+5,344
| New | +$338K | ﹤0.01% | 1880 |
|
|
2020
Q4 | – | Sell |
-26,422
| Closed | -$797K | – | 2502 |
|
|
2020
Q3 | $797K | Buy |
26,422
+3,632
| +16% | +$110K | 0.01% | 1060 |
|
|
2020
Q2 | $744K | Buy |
22,790
+12,799
| +128% | +$418K | 0.01% | 1090 |
|
|
2020
Q1 | $268K | Sell |
9,991
-10,368
| -51% | -$278K | 0.01% | 1338 |
|
|
2019
Q4 | $623K | Sell |
20,359
-23,538
| -54% | -$720K | ﹤0.01% | 1602 |
|
|
2019
Q3 | $1.06M | Sell |
43,897
-20,103
| -31% | -$484K | 0.01% | 1171 |
|
|
2019
Q2 | $1.62M | Buy |
64,000
+17,889
| +39% | +$453K | 0.02% | 951 |
|
|
2019
Q1 | $899K | Buy |
46,111
+3,207
| +7% | +$62.5K | 0.01% | 1153 |
|
|
2018
Q4 | $566K | Buy |
42,904
+21,804
| +103% | +$288K | 0.01% | 1169 |
|
|
2018
Q3 | $375K | Buy |
+21,100
| New | +$375K | ﹤0.01% | 1439 |
|